Organon Pharma Indonesia Tbk. vs Indosterling Technomedia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Indosterling Technomedia Tbk. trades at Rp50 (market cap 62.82B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | TECH | |
|---|---|---|
Market Cap | 104.4B | 62.82B |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Indosterling Technomedia Tbk (the Company) was established based on Notarial DeedNo. 97 dated January 19, 2011 of public notary Humberg Lie,S.H., MKn, a notary in Jakarta
Read more on TECH →